| 28 avr. 2026 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 13 099 | 14.33 USD | 10b5-1 |
| 28 avr. 2026 | SALE | Kiniksa Pharmaceuticals International, plc | 13 099 | 50.10 USD | 10b5-1 |
| 28 avr. 2026 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 13 099 | 0.00 USD | 10b5-1deriv |
| 12 févr. 2026 | SALE | Kiniksa Pharmaceuticals International, plc | 2 690 | 45.00 USD | |
| 12 févr. 2026 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 2 690 | 15.47 USD | |
| 10 févr. 2026 | SALE | Kiniksa Pharmaceuticals International, plc | 110 | 45.00 USD | |
| 10 févr. 2026 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 110 | 15.47 USD | |
| 10 févr. 2026 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 110 | 0.00 USD | deriv |
| 12 févr. 2026 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 2 690 | 0.00 USD | deriv |
| 02 févr. 2026 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 830 | 15.47 USD | |
| 02 févr. 2026 | SALE | Kiniksa Pharmaceuticals International, plc | 830 | 45.00 USD | |
| 03 févr. 2026 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 12 528 | 15.47 USD | |
| 03 févr. 2026 | SALE | Kiniksa Pharmaceuticals International, plc | 12 528 | 45.27 USD | |
| 04 févr. 2026 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 2 602 | 15.47 USD | |
| 04 févr. 2026 | SALE | Kiniksa Pharmaceuticals International, plc | 2 602 | 45.02 USD | |
| 04 févr. 2026 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 2 602 | 0.00 USD | deriv |
| 02 févr. 2026 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 830 | 0.00 USD | deriv |
| 03 févr. 2026 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 12 528 | 0.00 USD | deriv |
| 15 déc. 2025 | SALE | Kiniksa Pharmaceuticals International, plc | 20 129 | 41.51 USD | |
| 15 déc. 2025 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 20 129 | 10.36 USD | |
| 15 déc. 2025 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 20 129 | 0.00 USD | deriv |
| 09 juin 2025 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 6 900 | 3.80 USD | |
| 09 juin 2025 | SALE | Kiniksa Pharmaceuticals International, plc | 6 900 | 30.26 USD | |
| 10 juin 2025 | SALE | Kiniksa Pharmaceuticals International, plc | 8 212 | 30.36 USD | |
| 11 juin 2025 | EXERCISE | Kiniksa Pharmaceuticals International, plc | 12 336 | 3.80 USD | |